Skip to Content

Join the 'Head and Neck Cancer' group to help and get support from people like you.

Head and Neck Cancer News

Related terms: Oral Cancer

Health Tip: Recognize Symptoms of Oral Cancer

Posted 10 Nov 2017 by Drugs.com

-- Oral cancer typically is diagnosed between the ages of 55 and 64. It tends to affect more men than women, and will make up about 3 percent of all cancers diagnosed in 2017. The American Dental Association says symptoms of oral cancer may include: A mouth sore or irritation that does not go away within 3weeks. Red or white patches. A lump. Rough spots on normally smooth areas of the mouth. Unexplained ear or throat trouble. Frequent hoarseness while talking. Read more

Related support groups: Cancer, Oral and Dental Conditions, Dental Abscess, Head and Neck Cancer, Prevention of Dental Caries, Salivary Gland Cancer

1 in 9 American Men Infected With Oral HPV

Posted 16 Oct 2017 by Drugs.com

MONDAY, Oct. 16, 2017 – Eleven million American men are infected with oral human papillomavirus (HPV), which can lead to cancers of the head, neck and throat, a new study reports. That equates to 1 in 9 U.S. males aged 18 to 69. And infection is most likely for those who have had multiple oral sexual partners, are gay or bisexual, or who also have genital HPV infection, a team of U.S. researchers found. The most common cancer caused by the sexually transmitted virus is oropharyngeal squamous cell carcinoma, a head and neck cancer that's far more common in men than women, according to the study. "The incidence of this cancer has increased 300 percent in the last 20 years," said lead researcher Ashish Deshmukh. He's a research assistant professor at the University of Florida College of Public Health and Health Professions. Deshmukh and colleagues used 2011-2014 data from the U.S. ... Read more

Related support groups: Cancer, Human Papilloma Virus, Condylomata Acuminata, Gardasil, Head and Neck Cancer, Cervical Dysplasia, Human Papillomavirus Vaccine, Human Papillomavirus Prophylaxis, Cervarix, Vaccination and Prophlaxis, Gardasil 9

New Guideline Aims to Help Doctors Diagnose Head, Neck Masses

Posted 12 Sep 2017 by Drugs.com

TUESDAY, Sept. 12, 2017 – Neck masses are common in adults, but the cause is often hard to pinpoint. Now, doctors have a new guideline to help them make that call. The guideline from the American Academy of Otolaryngology – Head and Neck Surgery dovetails with a rise in head and neck cancers related to the sexually transmitted human papilloma virus (HPV). "A neck mass may indicate a serious medical problem. It does not mean the patient has cancer, but it does mean they need more medical evaluation to make a diagnosis," said Dr. M. Boyd Gillespie, assistant chairman of the group that developed the guideline. In an academy news release, he called the new guideline "an important instrument for the early diagnosis and treatment." A neck mass – an abnormal lump – can be any size and can be due to a number of reasons. It can be a sign of viral or bacterial infection. A neck mass could ... Read more

Related support groups: Bacterial Infection, Sexually Transmitted Diseases, Human Papilloma Virus, Gardasil, Viral Infection, Head and Neck Cancer, Deep Neck Infection, Human Papillomavirus Vaccine, Diagnosis and Investigation, Human Papillomavirus Prophylaxis, Cervarix, Solid Tumors, Salivary Gland Cancer, Gardasil 9

Cancer Takes Financial Toll, Even With Insurance

Posted 10 Aug 2017 by Drugs.com

THURSDAY, Aug. 10, 2017 – Many cancer patients in the United States are shocked by their out-of-pocket costs for care – with some spending one-third of their income on treatment, a new study finds. The study looked at the financial toll of cancer treatment on people who have health insurance. The vast majority in the study had private insurance or Medicare coverage; the rest were on Medicaid, the government insurance program for poor Americans. Despite that, the study found, patients typically spent nearly $600 a month on their treatment. Overall, 16 percent said they were facing "high or overwhelming financial distress." Those patients were spending nearly one-third of their monthly income on cancer care. Dr. Yousuf Zafar, the senior researcher on the study, used the term "financial toxicity." "Oncologists talk about the toxicities of cancer treatment. But there can also be a ... Read more

Related support groups: Anxiety and Stress, Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Skin Cancer, Small Cell Lung Cancer, Melanoma - Metastatic, Stomach Cancer, Head and Neck Cancer, Testicular Cancer, Gastric Cancer, Choriocarcinoma

Blood Test Can Screen for Rare Sinus Cancer, Study Finds

Posted 10 Aug 2017 by Drugs.com

WEDNESDAY, Aug. 9, 2017 – A new DNA blood test can catch a rare but deadly form of cancer that occurs in the sinuses, researchers report. The test, which looks for DNA evidence of Epstein-Barr virus in blood samples, was 97 percent accurate at detecting the presence of nasopharyngeal cancer, according to the results of a clinical trial. "I believe that the test is technologically ready for use for screening nasopharyngeal cancer in high-risk areas like Hong Kong," said senior researcher Dennis Lo. He's an associate dean of research and director of the Li Ka Shing Institute of Health Sciences with the Chinese University of Hong Kong. The nasopharynx is the upper part of the throat that lies behind the nose, just above the soft part of the roof of the mouth and just behind the nasal passages, according to the American Cancer Society (ACS). It serves as a passageway for air between the ... Read more

Related support groups: Cancer, Head and Neck Cancer, Diagnosis and Investigation

Gum Disease May Be Linked to Cancer Risk in Older Women

Posted 1 Aug 2017 by Drugs.com

TUESDAY, Aug. 1, 2017 – A new study links gum disease with an increased risk of several types of cancer in postmenopausal women, even in women who never smoked. So-called periodontal disease was tied to a 14 percent higher risk of developing any type of cancer, the investigators found. But the greatest risk was for esophageal cancer, which was more than three times more likely in older women who had gum disease than those who didn't. In addition, gum disease was associated with a higher risk of lung cancer, gallbladder cancer, melanoma and breast cancer, the findings showed. "These findings may provide a new target to test an intervention for cancer prevention – oral hygiene and periodontal disease treatment and prevention," said lead researcher Jean Wactawski-Wende. She is dean of the School of Public Health and Health Professions at the State University of New York at Buffalo. ... Read more

Related support groups: Cancer, Breast Cancer, Oral and Dental Conditions, Lung Cancer, Gingivitis, Melanoma, Head and Neck Cancer, Periodontitis, Gastric Cancer, Diagnosis and Investigation, Prevention of Dental Caries, Salivary Gland Cancer

Treatment Costs Can Be Another Blow to Cancer Patients

Posted 27 Jul 2017 by Drugs.com

THURSDAY, July 27, 2017 – The emotional and physical costs of cancer can be staggering. But the financial side of cancer is also a great burden, with many patients in the United States struggling to pay for treatment, new research reveals. "The current health law has greatly improved access to meaningful health coverage for cancer patients, survivors and all those with chronic diseases," Chris Hansen, president of the American Cancer Society Cancer Action Network, said in a network news release. "Yet costs remain a challenge for those facing cancer. Our country and our lawmakers should come together to find bipartisan solutions that begin to address patient costs without sacrificing the quality of coverage," he urged. Researchers surveyed financial navigators at 11 hospitals in nine states. Financial navigators – typically trained social workers or nurses – help cancer patients ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Breast Cancer, Lupron, Prostate Cancer, Medroxyprogesterone, Tamoxifen, Arimidex, Lupron Depot, Femara, Gleevec, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Anastrozole, Brain Tumor, Letrozole, Skin Cancer, Tarceva

Insured, But Still Barred From Top-Tier Cancer Centers

Posted 20 Jul 2017 by Drugs.com

THURSDAY, July 20, 2017 – Choosing a cheaper health plan could cost you access to cream-of-the-crop cancer doctors and facilities, a new study reports. Less-expensive "narrow network" health plans are much less likely to cover treatment by doctors at centers affiliated with the U.S. National Cancer Institute, said study lead author Laura Yasaitis. "We found that the narrower networks were more likely to systematically exclude NCI-affiliated physicians," said Yasaitis, a postdoctoral researcher with the University of Pennsylvania School of Medicine. "The oncologists they included in their networks were about half as likely to be NCI-affiliated as those they excluded." NCI-Designated Cancer Centers are the nation's top-flight facilities for cancer care, and studies have shown that patients treated at these centers tend to have better outcomes, Yasaitis said. Access to these centers is ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Brain Tumor, Cervical Cancer, Breast Cancer, Prevention, Head and Neck Cancer, Gastric Cancer

More Patients OK'd for Cancer Trials Under Obamacare: Study

Posted 20 Jul 2017 by Drugs.com

THURSDAY, July 20, 2017 – The Affordable Care Act has enabled more privately insured patients to enroll in clinical trials for new cancer treatments, a new study contends. Speedy approvals are important for patients who want to participate in clinical trials, said study author Dr. David Hong. He's deputy chair of investigational cancer therapeutics at the University of Texas MD Anderson Cancer Center. Since 2000, Medicare, the publicly funded insurance program for seniors, has covered routine costs of clinical trial participation. But coverage for patients with private insurance differed by insurer and state, the researchers noted. Under the ACA, or Obamacare, however, private insurers had to cover "standard of care" costs of clinical trial participation as of 2014. For this study, the researchers analyzed more than 2,400 patient referrals to the Clinical Center for Targeted Therapy at ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Gleevec, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Votrient, Tarceva, Avastin, Tasigna, Sprycel, Pancreatic Cancer, Sutent, Afinitor, Nexavar, Cisplatin, Carboplatin, Erbitux, Stomach Cancer

Many Terminal Cancer Patients Remain in Denial

Posted 20 Jul 2017 by Drugs.com

WEDNESDAY, July 19, 2017 – Nearly 10 percent of patients with terminal cancer don't want to know they're dying, which can make their final days more difficult, a new study finds. Unwillingness to face poor prospects can lead to unnecessary treatments and keep patients from making end-of-life plans, the researchers reported recently in The Oncologist. "Health care professionals should appropriately assess patients' readiness for prognostic information," said study leader Siew-Tzuh Tang, a professor at Chang Gung University School of Nursing in Taiwan. Doctors should respect patients' reluctance to confront their poor prognosis if they are not ready to know, "but sensitively coach them to cultivate their accurate prognostic awareness," Tang said in a journal news release. The study involved nearly 250 terminal cancer patients in Taiwan. They were questioned several times over their last ... Read more

Related support groups: Anxiety, Generalized Anxiety Disorder, Anxiety and Stress, Cancer, Post Traumatic Stress Disorder, Social Anxiety Disorder, Breast Cancer, Prostate Cancer, Renal Cell Carcinoma, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Skin Cancer, Ovarian Cancer, Pancreatic Cancer, Cervical Cancer, Breast Cancer, Prevention, Head and Neck Cancer

Doctors' Group Offers Ideas for Easing Cancer Costs

Posted 19 Jul 2017 by Drugs.com

WEDNESDAY, July 19, 2017 – New cancer drugs routinely cost $100,000 a year or more, and older cancer drugs are rising in price, too. Now, the American Society of Clinical Oncology (ASCO) has some suggestions for easing patients' money woes. The proposals include allowing Medicare to negotiate drug prices, legalizing the importation of drugs, and adopting bundled, or group, payment programs. In the new policy statement, ASCO also says it supports creation of a panel of "stakeholders" in health care to determine the effectiveness of its proposals. Such a group might also outline a uniform approach for assessing the value of drugs. "In what, undoubtedly, is one of the most difficult times in their lives, individuals with cancer should be focused on getting the best care possible, not worrying about financial strain on their families," said Dr. Clifford Hudis. He's CEO of ASCO, a leading ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Methotrexate, Breast Cancer, Lupron, Prostate Cancer, Medroxyprogesterone, Tamoxifen, Fluorouracil, Arimidex, Lupron Depot, Femara, Gleevec, Lung Cancer, Colorectal Cancer, Anastrozole, Votrient, Brain Tumor, Letrozole

Do Blacks, Hispanics Get Low Quality Hospice Care?

Posted 6 Jul 2017 by Drugs.com

WEDNESDAY, July 5, 2017 – Hospice quality varies, with blacks and Hispanics often getting less desirable end-of-life care, a new study finds. Researchers surveyed thousands of caregivers whose loved ones died in hospice care. They found that minority patients were more likely to receive care in poorer quality hospices than white patients. They also said that family caregivers of black and Hispanic hospice patients were less likely to receive adequate emotional and religious support. "Our findings highlight the need to ensure that blacks and Hispanics have access to high-quality and culturally competent hospice services," said study lead author Rebecca Anhang Price, a senior policy researcher at the RAND Corp. "This is particularly important as people from these groups increase their use of hospice services," she added in a RAND news release. The report wasn't all bad news for ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Skin Cancer, Head and Neck Cancer, Breast Cancer - Palliative, Gastric Cancer

Publicly Funded Cancer Trials Gained Americans 3 Million More Years

Posted 6 Jun 2017 by Drugs.com

TUESDAY, June 6, 2017 – Public-funded trials have significantly extended the lives of people diagnosed with cancer, according to new research. SWOG, the clinical trials network funded by the U.S. National Cancer Institute (NCI), has involved more than 200,000 patient volunteers. These trials have led to approval of 14 new cancer drugs and more than 100 changes to cancer care standards. All told, the clinical trials studied extended life by 3.34 million years, the study found. SWOG estimates the dollar return on investment from federal funding at $125 for each year of life gained. "A lot of people with cancer have lived longer because of the therapies tested in our publicly funded trials," study leader Joseph Unger said in a SWOG news release. He is an assistant member of the Fred Hutchinson Cancer Research Center's Cancer Prevention Program in Seattle. "At the same time, the cost of ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Methotrexate, Breast Cancer, Accutane, Lupron, Prostate Cancer, Medroxyprogesterone, Tamoxifen, Tretinoin, Fluorouracil, Arimidex, Lupron Depot, Femara, Gleevec, Lung Cancer, Rituxan, Isotretinoin, Colorectal Cancer

Reporting Symptoms Online to Docs Helps Cancer Patients Live Longer

Posted 4 Jun 2017 by Drugs.com

SUNDAY, June 4, 2017 – When people with advanced cancer report their symptoms to health care providers using an online program, they may live longer, a new study suggests. The benefit may come because the new online tool cuts any "lag time" between patients experiencing symptoms and their care team's response to those issues, the researchers said. "Patients receiving chemotherapy often have severe symptoms, but doctors and nurses are unaware of these symptoms up to half of the time," explained study author Dr. Ethan Basch, a professor of medicine at the University of North Carolina's Lineberger Comprehensive Cancer Center. Dr. Bruce Johnston, President-Elect of the American Society of Clinical Oncology (ASCO), said the new technology addresses a common problem in cancer care. "A lot of patients are reluctant to contact docs between visits – they may think, 'I don't feel too good, but ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, Head and Neck Cancer

Experimental Gene-Targeted Drug Hits Cancer Where It Lives

Posted 4 Jun 2017 by Drugs.com

SATURDAY, June 3, 2017 – An experimental drug that targets a specific gene mutation can battle a range of advanced cancers in adults and children, researchers are reporting. The genetic abnormality is known as a TRK fusion, and it's found in only a small percentage of all cancers. So the drug, called larotrectinib, is no panacea. But researchers found that among 50 patients with TRK fusions, 76 percent saw their cancer regress after starting larotrectinib – regardless of their age or type of cancer. For most of those patients – 79 percent – the response has lasted at least one year, according to lead researcher Dr. David Hyman. "There are few therapies that have had that kind of success for patients like these," said Hyman, an oncologist at Memorial Sloan Kettering Cancer Center in New York City. Dr. William Oh, an oncologist who was not involved in the study, agreed. "A 76 percent ... Read more

Related support groups: Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Keytruda, Head and Neck Cancer, Pembrolizumab, Salivary Gland Cancer

Page 1 2 3 4 5 6 7 Next

Ask a Question

Further Information

Related Condition Support Groups

Salivary Gland Cancer, Cancer

Related Drug Support Groups

methotrexate, Opdivo, Keytruda, Taxotere, Erbitux, nivolumab, pembrolizumab, cetuximab, docetaxel, Methotrexate LPF Sodium, Trexall, Folex PFS